UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000024546
Receipt number R000028246
Scientific Title Cross-over study on the effectiveness of meta-cognitive training for schizophrenic patients
Date of disclosure of the study information 2017/12/30
Last modified on 2021/04/28 10:44:36

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Cross-over study on the effectiveness of meta-cognitive training for schizophrenic patients

Acronym

Effectiveness of meta-cognitive training for schizophrenic patients

Scientific Title

Cross-over study on the effectiveness of meta-cognitive training for schizophrenic patients

Scientific Title:Acronym

Effectiveness of meta-cognitive training for schizophrenic patients

Region

Japan


Condition

Condition

Schizophrenia

Classification by specialty

Psychiatry Rehabilitation medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Cross-over study on the effectiveness of meta-cognitive training for schizophrenic patients

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Change of score of Brief Assessment of Cognition in Schizophrenia (BACS) after 4 months intervention

Key secondary outcomes

Positive and Negative Syndrome Scale (PANSS)


Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification

YES

Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Educational,Counseling,Training

Type of intervention

Behavior,custom Maneuver

Interventions/Control_1

metacognitive training (MCT)

Interventions/Control_2

Regular Program of occupational therapy

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

65 years-old >

Gender

Male and Female

Key inclusion criteria

1) A person who has been diagnosed with schizophrenia or schizoaffective disorder by the DSM-IV-TR.
2) Those who are hospitalized more than a month in a psychiatric hospital.
3) Patients who have implemented occupational therapy.
4)Those who have agreed to participate in the study.

Key exclusion criteria

1) patients less than or more than 65-year-old 20-year-old.
2) Patients to merge intellectual disorder, alcohol-drug dependence (substance abuse-dependent), dementia, epilepsy, head trauma, cerebral vascular disease, etc.
3) Patients less than 1 month after admission.
4) Patients MCT-J and cognitive function tests can not be carried out because of an unstable medical condition.
5) Patients who do not have implemented the Occupational Therapy.
6) Those who do not agree to participate in the study.
7) Patients who have been determined to be unsuitable for study by the physician and principal investigator.

Target sample size

40


Research contact person

Name of lead principal investigator

1st name Masayoshi
Middle name
Last name Kobayashi

Organization

Shinshu University Graduate School of Medicine

Division name

Health Science

Zip code

390-8621

Address

Matsumoto

TEL

0263372403

Email

mkobaya@shinshu-u.ac.jp


Public contact

Name of contact person

1st name Masayoshi
Middle name
Last name Kobayashi

Organization

Shinshu University Graduate School of Medicine

Division name

Health Science

Zip code

390-8621

Address

Matsumoto

TEL

0263372403

Homepage URL


Email

mkobaya@shinshu-u.ac.jp


Sponsor or person

Institute

Shinshu University Graduate School of Medicine

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Shinshu University Graduate School of Medicine

Address

3-1-1

Tel

0263372403

Email

mkobaya@shinshu-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2017 Year 12 Month 30 Day


Related information

URL releasing protocol

https://www.jstage.jst.go.jp/article/asiajot/17/1/17_45/_article/-char/en

Publication of results

Published


Result

URL related to results and publications

https://www.jstage.jst.go.jp/article/asiajot/17/1/17_45/_article/-char/en

Number of participants that the trial has enrolled

22

Results

No significant differences were seen in inter-group comparisons of the scores of various scales at the baseline. Four months and eight months later, a comparison between before and after MCT showed improvement tendencies for both groups in the participants' cognitive function and psychiatric symptoms. A comparison of scores before and after the MCT intervention period, from all participants, showed significant improvement tendencies in their verbal memory and attention.

Results date posted

2021 Year 04 Month 28 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics

Participating in this study were patients who were diagnosed with schizophrenia by a psychiatrist, based on the diagnostic criteria of the Diagnostic and Statistical Manual of Mental Disorders 5th edition (DSM-5), were admitted to a psychiatric hospital's long-term care ward, and were undergoing occupational therapy. As part of the enrollment criteria for participation, individuals had to be between the ages of 20 and 65 years. The following individuals were excluded: those with intellectual disability and a history of substance abuse and/or dependence, dementia, epilepsy, head injury, and cerebrovascular diseases. Those with unstable disease condition and those whom either a psychiatrist or an occupational therapist had determined as unfit for the study were also excluded.

Participant flow

Of the 43 patients hospitalized inside the long-term care ward, 22 took part in this study. Eleven individuals were randomly allocated to Groups A and B. During the follow-up period, one individual in Group A was discharged from the hospital, and another individual withdrew their consent, while two individuals in Group B were discharged, and another individual withdrew their consent. In the end, nine individuals in Group A (male-to-female ratio = 6:3), and eight in Group B (male-to-female = 4:4) were analyzed.

Adverse events

None

Outcome measures

Four measures were used: the Brief Assessment of Cognition in Schizophrenia (BACS), the Positive and Negative Syndrome Scale (PANSS), the Global Assessment of Functioning (GAF), and the Beck Cognitive Insight Scale (BCIS).

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2016 Year 09 Month 06 Day

Date of IRB

2016 Year 09 Month 06 Day

Anticipated trial start date

2016 Year 11 Month 01 Day

Last follow-up date

2020 Year 03 Month 30 Day

Date of closure to data entry

2020 Year 03 Month 30 Day

Date trial data considered complete

2020 Year 03 Month 30 Day

Date analysis concluded

2020 Year 03 Month 30 Day


Other

Other related information



Management information

Registered date

2016 Year 10 Month 24 Day

Last modified on

2021 Year 04 Month 28 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000028246


Research Plan
Registered date File name
2021/04/28 研究計画書.pdf

Research case data specifications
Registered date File name
2021/04/28 症例報告書(小林・藤井).xlsx

Research case data
Registered date File name
2021/04/28 症例報告書.xlsx